Transient neonatal galactosaemia has been reported three times: twice in infants undergoing evaluation for failure to thrive, with rapid clinical and biochemical response to a galactose-free diet; and once in an infant identified by newborn screening (Bracco et al 1988;Taylor et al 1988;Cheetham 1989). In two of these infants, a diagnosis of cystic fibrosis was subsequently made (Cheetham 1989; R.J. Pollitt, personal communication, 1992). We report another infant with transient neonatal galactosaemia, who does not have cystic fibrosis, who was identified as a result of newborn screening.This Black female was delivered at 33 weeks' gestation, with a birth weight of 2.01 kg (50th centile). The initial newborn screen, obtained on day 10, resulted in a negative Beutler test (Beutler and Baluda 1966) for galactose-l-phosphate-uridyltransferase (GALT) deficiency but a borderline elevation of total galactose/gal-l-P (10 20 mg/dl whole blood; normal 0-10). When repeated on day 32, the Beutler test again was negative but the galactose/gal-l-P was elevated to 20-40mg/dl whole blood. When seen at 5½ weeks of age, the patient was thriving and there was no feeding intolerance, irritability, lethargy or jaundice. Ophthalmological evaluation revealed the presence of very small lens opacities bilaterally and also bilateral, symmetric macular holes of unclear aetiology. Urine was weakly positive for reducing substances (0.25% by Clinitest). Quantitative erythrocyte gal-l-P was 1.0 mg/100ml RBC (normal <_ 2.0); GALT activity was 14.5 nmol/h per g Hb (control range 18-35); and galactokinase was 2.9/~mol/h per g Hb (control range 0.9-4.4). The baby was initially placed on a soy-based, lactose-free diet (Prosobee, Mead Johnson) but was restarted on a galactose-containing formula (Enfamil, Mead Johnson) at 9 weeks of age, when normal GALT and galactokinase activities were documented. One week later the galactose/gal-l-P rose to 80mg/dl and the urine was strongly positive for reducing substances (0.75% by Clinitest). The red cell gal-l-P was minimally elevated (2.2mg/100ml RBC) but both plasma and urine galactose levels were markedly elevated at 18.5 mg/dl (control 0-1) and 22.7 g/g creatinine (control < 0.2), respectively. Although liver function tests were not performed, the plasma and urine amino acid profiles suggested mild liver dysfunction. A galactose-free diet was reinstituted at 10 weeks of age. At 5½ months, a repeat ophthalmological examination was normal. Amino acid profiles were within normal limits and she was restarted on a galactosecontaining formula. Her urine remained free of reducing substances. At 30 months